Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CASR | P41180 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7023578 | 0.93 | ADRB1 (0.50) | KDM4EALDH1A1ADRB1ATMCASR | |
| SCHEMBL7021520 | 0.89 | ADRB1 (0.47) | KDM4EALDH1A1ADRB1ATMCASR | |
| SCHEMBL7023503 | 0.80 | MEN1 (0.64) | ADRB1ATMMEN1KMT2AADRB3 | |
| SCHEMBL7027570 | 0.79 | ADRB1 (0.56) | ADRB1ADRB3ADRB2 | |
| SCHEMBL7024944 | 0.76 | ADRB1 (0.50) | KDM4EALDH1A1ADRB1ATMCASR | |
| SCHEMBL7024050 | 0.73 | MEN1 (0.61) | ADRB1ATMMEN1KMT2AADRB3 | |
| SCHEMBL7597017 | 0.70 | MEN1 (0.53) | ADRB1MEN1KMT2AADRB3ADRB2 | |
| SCHEMBL7030624 | 0.69 | POLB (0.56) | ALDH1A1ADRB1MEN1KMT2ACYP1A2 | |
| SCHEMBL7024447 | 0.68 | MEN1 (0.67) | ADRB1ATMMEN1KMT2AADRB3 | |
| SCHEMBL6320450 | 0.68 | CASR (0.58) | KDM4EALDH1A1ADRB1ATMCASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030032834-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032834-A1 | Aminoalcohol derivatives | ADRB1, ADRB2, ADRB3 | KDM4E 3496/4885ALDH1A1 318/4885ADRB1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.